RELV / Reliv' International, Inc. - SEC Filings, Annual Report, Proxy Statement

Reliv' International, Inc.
US ˙ OTCPK

Basic Stats
LEI 5493003YFMHGJVETEU44
CIK 768710
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Reliv' International, Inc.
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
January 19, 2021 SC 13E3/A

- SCHEDULE 13E3/A

SC 13E3/A 1 relv20210115sc13e3a.htm SCHEDULE 13E3/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 3-Final Amendment) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name

January 19, 2021 15-12G

- FORM 15-12G

15-12G 1 relv202101151512g.htm FORM 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES AND EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 000-19932 RELIV INTERNATIONAL, IN

December 23, 2020 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

December 21, 2020 25

- FORM 25

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-19932 RELIV INTERNATIONAL, INC. THE NASDAQ STOCK MARKET LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

December 7, 2020 EX-99.1

Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common Stock CHESTERFIELD, MO, December 4, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional

December 7, 2020 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

8-K 1 relv202012048k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpora

November 24, 2020 SC 13E3/A

- SCHEDULE 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 2) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per s

November 24, 2020 DEF 14C

- FORM DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☒ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

November 20, 2020 PRER14C

- FORM PRER14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

November 18, 2020 PRER14C

- FORM PRER14C

PRER14C 1 relv20201118bprer14c.htm FORM PRER14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information

November 18, 2020 SC 13E3/A

- SCHEDULE 13E3/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3/A (Rule 13e-100) (Amendment No. 1) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. ROBERT L. MONTGOMERY STEPHEN M. MERRICK (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per s

November 17, 2020 CORRESP

-

Reliv International, Inc. 136 Chesterfield Industrial Blvd. Chesterfield, MO 63005 November 17, 2020 Via EDGAR Mr. Valian A. Afshar Special Counsel Office of Mergers and Acquisitions Securities and Exchange Commission Division of Corporation Finance Washington, DC 20549 Re: Reliv? International, Inc. Preliminary Information Statement on Schedule 14C Filed on October 21, 2020 File No. 0-19932 Sched

November 13, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

November 13, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 13, 2020 EX-99.1

Reliv International Reports Third-Quarter Financial Results for 2020

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2020 CHESTERFIELD, MO, November 13, 2020 – Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today reported its financial results for the th

November 9, 2020 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

November 9, 2020 EX-10.1

Loan Agreement between Enterprise Bank and Trust and Reliv International, Inc., Reliv World Corporation, Reliv, Inc., SL Technology, Inc., and Chesterfield Partners LLC dated November 5, 2020 (filed herewith).

EX-10.1 2 ex212481.htm EXHIBIT 10.1 Exhibit 10.1 LOAN AGREEMENT THIS LOAN AGREEMENT, dated as of November 5, 2020, is made and entered into by and among RELIV’, INC., an Illinois corporation, RELIV’ INTERNATIONAL, INC., a Delaware corporation, RELIV’ WORLD CORPORATION, an Illinois corporation, SL TECHNOLOGY, INC., a Missouri corporation, and CHESTERFIELD PARTNERS LLC, a Missouri limited liability

November 9, 2020 EX-10.2

Promissory Note between Enterprise Bank and Trust and Reliv International, Inc., Reliv World Corporation, Reliv, Inc., SL Technology, Inc., and Chesterfield Partners LLC dated November 5, 2020 (filed herewith).

EX-10.2 3 ex212482.htm EXHIBIT 10.2 Exhibit 10.2 PROMISSORY NOTE $4,000,000.00 November 5, 2020 FOR VALUE RECEIVED, the undersigned, RELIV’, INC., an Illinois corporation, RELIV’ INTERNATIONAL, INC., a Delaware corporation, RELIV’ WORLD CORPORATION, an Illinois corporation, SL TECHNOLOGY, INC., a Missouri corporation, and CHESTERFIELD PARTNERS LLC, a Missouri limited liability company (collectivel

October 22, 2020 SC 13E3

- SCHEDULE 13E3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13E-3 (Rule 13e-100) RULE 13E-3 TRANSACTION STATEMENT UNDER SECTION 13(e) OF THE SECURITIES EXCHANGE ACT OF 1934 RELIV INTERNATIONAL, INC. (Name of the Issuer) RELIV INTERNATIONAL, INC. (Name of Person(s) Filing Statement) Common Stock, par value $0.001 per share (Title of Class of Securities) 75952 R 209 (CUSIP Numbe

October 21, 2020 PRE 14C

- FORM PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)2)) ☐ Definitive Information Statement RELIV INTERNATIONAL, INC. (Name of Re

October 19, 2020 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

8-K 1 relv202010168k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpora

October 19, 2020 EX-99.2

RELIV INTERNATIONAL, INC. SUMMARY OF “REVERSE STOCK SPLIT” TRANSACTION

EX-99.2 3 ex207312.htm EXHIBIT 99.2 Exhibit 99.2 RELIV INTERNATIONAL, INC. SUMMARY OF “REVERSE STOCK SPLIT” TRANSACTION Overview The Board of Directors of Reliv International, Inc., a Delaware corporation (the "Company" or “we”), approved resolutions proposing amendments to our Certificate of Incorporation (the "Certificate of Incorporation") to effect a reverse stock split of our Common Stock fol

October 19, 2020 EX-99.1

RELIV INTERNATIONAL, INC. ANNOUNCES REVERSE STOCK SPLIT TRANSACTION AND PLAN TO DELIST FROM NASDAQ AND DEREGISTER ITS COMMON STOCK

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION RELIV INTERNATIONAL, INC. ANNOUNCES REVERSE STOCK SPLIT TRANSACTION AND PLAN TO DELIST FROM NASDAQ AND DEREGISTER ITS COMMON STOCK CHESTERFIELD, MO, October 19, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements t

August 14, 2020 EX-99.1

Reliv International Reports Second-Quarter Financial Results for 2020

EX-99.1 2 ex199557.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2020 CHESTERFIELD, MO, August 14, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health

August 14, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202008138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporat

August 14, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

June 25, 2020 11-K

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

May 15, 2020 10-Q

Quarterly Report - FORM 10-Q

10-Q 1 relv2020033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

May 15, 2020 EX-99.1

Reliv International Reports First-Quarter Financial Results for 2020

EX-99.1 2 ex186819.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2020 CHESTERFIELD, MO, May 15, 2020 – Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, to

May 15, 2020 EX-10.1

Change in Terms Agreement (revolving credit facility) dated April 28, 2020 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

EX-10.1 2 ex185804.htm EXHIBIT 10.1 Exhibit 10.1

May 15, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202005148k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation

May 6, 2020 EX-10.1

Promissory Note between Enterprise Bank and Trust and Reliv International, Inc. dated April 20, 2020.

EX-10.1 2 ex184952.htm EXHIBIT 10.1 Exhibit 10.1

May 6, 2020 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K 1 relv202005058k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation)

March 27, 2020 EX-21

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S. de R.L. de C.V., organized under the laws of

March 27, 2020 10-K

RELV / Reliv' International, Inc. 10-K - Annual Report - FORM 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF

March 27, 2020 EX-99.1

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2019

EX-99.1 2 ex179168.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2019 CHESTERFIELD, MO, March 27, 2020 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, to

March 27, 2020 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv202003268k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2020 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporati

December 27, 2019 POS AM

RELV / Reliv' International, Inc. POS AM - - FORM POS AM

As filed with the Securities and Exchange Commission on December 27, 2019 SEC Registration No.

December 27, 2019 S-8 POS

RELV / Reliv' International, Inc. S-8 POS - - FORM S-8 POS

As filed with the Securities and Exchange Commission on December 27, 2019 Registration No.

December 27, 2019 POS AM

RELV / Reliv' International, Inc. POS AM - - FORM POS AM

As filed with the Securities and Exchange Commission on December 27, 2019 SEC Registration No.

December 27, 2019 S-8 POS

RELV / Reliv' International, Inc. S-8 POS - - FORM S-8 POS

S-8 POS 1 relv20191226bs8pos.htm FORM S-8 POS As filed with the Securities and Exchange Commission on December 27, 2019 Registration No. 333-67921 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 POST EFFECTIVE AMENDMENT NO. 1 TO REGISTRATION STATEMENT ON FORM S-8 UNDER THE SECURITIES ACT OF 1933 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter)

November 14, 2019 10-Q

RELV / Reliv' International, Inc. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 14, 2019 EX-99.1

Reliv International Reports Third-Quarter Financial Results for 2019

EX-99.1 2 ex164809.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2019 CHESTERFIELD, MO, November 14, 2019 – Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today repor

November 14, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 relv201911138k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorpor

August 14, 2019 EX-10.1

Agreement dated June 1, 2019 with Nutracom, LLC to modify Purchase Agreement and Secured Promissory Note dated January 1, 2019 (filed herewith).

EX-10.1 2 ex154249.htm EXHIBIT 10.1 Exhibit 10.1 AGREEMENT Agreement by and between Nutracom, LLC, a Missouri limited liability company (“Nutracom”), and Reliv International, Inc., a Delaware corporation (“Reliv”), entered into this first day of June, 2019. RECITALS WHEREAS, Nutracom and Reliv entered into a purchase agreement dated January 1, 2019 (the “Purchase Agreement”) whereby Reliv sold to

August 14, 2019 10-Q

RELV / Reliv' International, Inc. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 9, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

August 9, 2019 EX-99.1

Reliv International Reports Second-Quarter Financial Results for 2019

EX-99.1 2 ex154081.htm EXHIBIT 99.1 Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2019 CHESTERFIELD, MO, August 9, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported i

June 28, 2019 11-K

RELV / Reliv' International, Inc. 11-K - - FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

May 24, 2019 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 15, 2019 10-Q

RELV / Reliv' International, Inc. 10-Q Quarterly Report FORM 10-Q

10-Q 1 relv2019033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

May 10, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 10, 2019 EX-99.1

Reliv International Reports First-Quarter Financial Results for 2019

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2019 CHESTERFIELD, MO, May 10, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the first quar

April 5, 2019 DEF 14A

RELV / Reliv' International, Inc. FORM DEF 14A

DEF 14A 1 relv20190403def14a.htm FORM DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted

March 29, 2019 EX-99.1

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2018 CHESTERFIELD, MO, March 29, 2019 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results f

March 29, 2019 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 29, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

March 29, 2019 EX-10.28

Unsecured Term Note issued by Nutracom, LLC to Registrant dated January 1, 2019 (filed herewith).

EX-10.28 6 ex138961.htm EXHIBIT 10.28 Exhibit 10.28 UNSECURED TERM NOTE $764,343.51 January 1, 2019 This UNSECURED TERM NOTE is executed and delivered under and pursuant to that certain Purchase Agreement dated as of the date hereof by and among Reliv International, Inc., a Delaware corporation (“Company”) and Nutracom, LLC, a Missouri limited liability company (“Maker”). FOR VALUE RECEIVED, Maker

March 29, 2019 EX-10.30

Change in Terms Agreement (revolving credit facility) dated March 25, 2019 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

Exhibit 10.30

March 29, 2019 EX-21

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 29, 2019 EX-10.3

Carl W. Hastings Employment Agreement dated January 1, 2019 (filed herewith).

Exhibit 10.3 EMPLOYMENT AGREEMENT THIS AGREEMENT is made and entered into this 1st day of January, 2019, by and between Reliv' International, Inc., a Delaware corporation (the “Company”), and Carl W. Hastings (hereinafter referred to as the “Executive”). WHEREAS, the Executive is presently, and for some time has been, employed as an Executive of the Company, pursuant to the terms of an Employment

March 29, 2019 EX-10.29

Fourth Amendment to Loan Agreement dated March 25, 2019 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith)

Exhibit 10.29

March 29, 2019 EX-10.26

Lease between Registrant (lessor) and Nutracom, LLC (lessee) dated January 1, 2019 (filed herewith).

Exhibit 10.26 LEASE To Nutracom, LLC 138 Chesterfield Industrial Boulevard Chesterfield, MO 63005 January 1, 2019 Page 1 of 22 REFERENCE PAGE OF LEASE DATE OF LEASE: January 1, 2019 BUILDING: as shown on Exhibit “A” LESSOR: Reliv International, Inc. LESSOR’S ADDRESS: 136 Chesterfield Industrial Boulevard Chesterfield, MO 63005 LESSOR’S PHONE: (636) 733-1410 LESSOR’S CONTACT: Ryan A. Montgomery, Ch

March 29, 2019 10-K

RELV / Reliv' International, Inc. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF

March 29, 2019 EX-10.27

Secured Term Note issued by Nutracom, LLC to Registrant dated January 1, 2019 (filed herewith).

Exhibit 10.27 SECURED TERM NOTE $1,000,000 January 1, 2019 This SECURED TERM NOTE is executed and delivered under and pursuant to that certain Purchase Agreement dated as of the date hereof by and among Reliv International, Inc., a Delaware corporation (“Company”) and Nutracom, LLC, a Missouri limited liability company (“Maker”). FOR VALUE RECEIVED, Maker hereby promises to pay to the Company at t

March 29, 2019 EX-2.1

Purchase Agreement with Nutracom, LLC dated January 1, 2019 (filed herewith).

Exhibit 2.1 PURCHASE AGREEMENT Nutracom, LLC, a Missouri limited liability company (“Nutracom”), and Reliv International, Inc., a Delaware corporation (“Reliv”), enter into this Purchase Agreement for the purchase and sale of certain assets of the Nutracom Division of Reliv (the “Business”). RECITALS WHEREAS, the Nutracom and Reliv have completed negotiations regarding Nutracom’s proposed purchase

January 7, 2019 8-K

Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2019 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

November 14, 2018 10-Q

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 14, 2018 EX-10.2

Change in Terms Agreement (revolving credit facility) dated September 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 14, 2018).

Exhibit 10.2

November 14, 2018 EX-10.1

Third Amendment to Loan Agreement dated September 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 14, 2018).

Exhibit 10.1

November 9, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

November 9, 2018 EX-99.1

Reliv International Reports Third-Quarter Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2018 CHESTERFIELD, MO, November 9, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the third

August 30, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

August 14, 2018 10-Q

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 10, 2018 EX-99.1

Reliv International Reports Second-Quarter Financial Results for 2018

Exhibit 99.1 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2018 CHESTERFIELD, MO, August 10, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results for the second

August 10, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 10, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

July 3, 2018 EX-99.1

Reliv International Announces Executive Promotions

Exhibit 99.1 PRESS RELEASE Media Contact: Kurt Wulff [email protected] 636-733-1433 Reliv International Announces Executive Promotions CHESTERFIELD, MO, July 2, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promotes optimal health, today announced a series of internal executive promotions. Tom Pinnock to President of Sales and Marketing For over three de

July 3, 2018 8-K

Financial Statements and Exhibits

8-K 1 relv201807028k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation

June 13, 2018 11-K

RELV / Reliv' International, Inc. FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 1

June 8, 2018 EX-99.1

Reliv International Names Ryan Montgomery Chief Executive Officer

Exhibit 99.1 PRESS RELEASE Media Contact: Kurt Wulff [email protected] 636-733-1433 Reliv International Names Ryan Montgomery Chief Executive Officer CHESTERFIELD, MO, June 6, 2018 – Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promotes optimal health, today announced that its Board of Directors has appointed Ryan A. Montgomery to the position of Chief Executi

June 8, 2018 8-K

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 25, 2018 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 15, 2018 10-Q

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

10-Q 1 relv2018033110q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm

May 15, 2018 EX-10.2

Change in Terms Agreement (term loan) dated April 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (filed herewith).

Exhibit 10.2

May 15, 2018 EX-10.3

Change in Terms Agreement (revolving credit facility) dated April 30, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.3 to the Form 10-Q of the Registrant filed May 15, 2018).

Exhibit 10.3

May 15, 2018 EX-10.1

Second Amendment to Loan Agreement dated April 11, 2018 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed May 15, 2018).

Exhibit 10.1

May 11, 2018 EX-99

Reliv International Reports First-Quarter Financial Results for 2018

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2018 CHESTERFIELD, MO, May 11, 2018 – Reliv International, Inc.

May 11, 2018 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 11, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

April 6, 2018 DEF 14A

RELV / Reliv' International, Inc. FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State

March 29, 2018 10-K

RELV / Reliv' International, Inc. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2017 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13

March 29, 2018 EX-21

Subsidiaries of the Registrant (filed herewith).

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 27, 2018 8-K

RELV / Reliv' International, Inc. FORM 8-K (Current Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2018 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

March 27, 2018 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2017 CHESTERFIELD, MO, March 27, 2018 – Reliv International, Inc.

February 21, 2018 SC 13D

RELV / Reliv' International, Inc. / Montgomery Robert L - SCHEDULE 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 209 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

November 14, 2017 10-Q

RELV / Reliv' International, Inc. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 13, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

relv201711098k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-1993

November 13, 2017 EX-99

Reliv International Reports Third-Quarter Financial Results for 2017

ex100008.htm Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2017 CHESTERFIELD, MO, November 10, 2017 ? Reliv International, Inc. (NASDAQ:RELV), a maker of nutritional supplements that promote optimal health, today reported its financial results fo

August 14, 2017 10-Q

RELV / Reliv' International, Inc. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 11, 2017 EX-99

Reliv International Reports Second-Quarter Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2017 CHESTERFIELD, MO, August 11, 2017 ? Reliv International, Inc.

August 11, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

June 14, 2017 11-K

Reliv' International 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 1

May 26, 2017 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 12, 2017 EX-99

Reliv International Reports First-Quarter Financial Results for 2017

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2017 CHESTERFIELD, MO, May 12, 2017 ? Reliv International, Inc.

May 12, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 v4667448k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 12, 2017 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000

May 12, 2017 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

April 10, 2017 DEF 14A

Reliv' International DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

March 28, 2017 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2017 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

March 28, 2017 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2016 CHESTERFIELD, MO, March 28, 2017 ? Reliv International, Inc.

March 28, 2017 EX-10.18

Letter agreement between SL Technology, Inc. and Soy Labs, LLC dated September 2, 2016 (incorporated by reference to Exhibit 10.18 to the Form 10-K of the Registrant for the year ended December 31, 2016)

Exhibit 10.18 September 2, 2016 Dale R. Ludwig Managing Member Soy Labs, LLC 1150 Highway 50 West Linn, Missouri 65051 Dear Mr. Ludwig: This letter confirms and sets forth the terms of the agreement between Soy Labs, LLC (“Soy Labs”) and SL Technology, Inc. (“SLTI”) with respect to the assignment to SLTI of certain technology owned by Soy Labs and licensed by SLTI pursuant to that certain Technolo

March 28, 2017 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 28, 2017 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016

10-K 1 v46186110k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2016 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ¨ TRANSITIO

March 28, 2017 EX-3.2

Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.2 to the Form 10-K of the Registrant for the year ended December 31, 2016)

Exhibit 3.2 State of Delaware Secretary of State Division of Corporations Delivered 12:05 PM 09/30/2016 FILED 12:05 PM 09/30/2016 SR 20166015054 - File Number 3028773 CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RELIV’ INTERNATIONAL, INC. Pursuant to the provisions of the Delaware General Corporation Law, Reliv’ International, Inc., a Delaware corpora

March 24, 2017 PRE 14A

Reliv' International PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

January 31, 2017 SC 13D

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

November 14, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

November 14, 2016 EX-10.1

First Amendment to Loan Agreement dated September 30, 2016 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 14, 2016).

EX-10.1 2 v452060ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 FIRST AMENDMENT TO LOAN AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2016 04-30-2018 8197223 UG *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitte

November 14, 2016 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 14, 2016 EX-10.2

Change in Terms Agreement (revolving credit facility) dated September 30, 2016 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 14, 2016).

Exhibit 10.2 CHANGE IN TERMS AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2016 04-30-2018 8197223 UG *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV

November 14, 2016 EX-99

Reliv International Reports Third-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results for 2016 CHESTERFIELD, MO, November 11, 2016 ? Reliv International, Inc.

October 6, 2016 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2016 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

September 16, 2016 8-K

Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 15, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

September 16, 2016 EX-99

Reliv International Announces Reverse Stock Split

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Announces Reverse Stock Split CHESTERFIELD, MO, September 15, 2016 ? Reliv International, Inc.

August 15, 2016 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 12, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

August 12, 2016 EX-99

Reliv International Reports Second-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2016 CHESTERFIELD, MO, August 12, 2016 ? Reliv International, Inc.

August 12, 2016 EX-99

Reliv International Reports Second-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results for 2016 CHESTERFIELD, MO, August 12, 2016 ? Reliv International, Inc.

August 12, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

June 16, 2016 11-K

Reliv' International FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION

May 27, 2016 8-K

Submission of Matters to a Vote of Security Holders

8-K 1 v4411498k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 26, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000

May 13, 2016 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV? I

May 13, 2016 EX-99

Reliv International Reports First-Quarter Financial Results for 2016

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2016 CHESTERFIELD, MO, May 13, 2016 ? Reliv International, Inc.

May 13, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2016 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 3, 2016 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 29, 2016 RELIV? INTERNATIONAL, INC.

April 11, 2016 DEF 14A

Reliv' International DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy State

March 29, 2016 PRE 14A

Reliv' International PRE 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

March 24, 2016 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2015 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13

March 24, 2016 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2016 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

March 24, 2016 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 24, 2016 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2015

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2015 CHESTERFIELD, MO, March 24, 2016 ? Reliv International, Inc.

February 3, 2016 SC 13D

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

SC 13D 1 v430454sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63

November 13, 2015 EX-10.4

Deed of Trust dated September 30, 2015 between Reliv International, Inc. as Grantor and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.4 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.4 DEED OF TRUST WITH FUTURE ADVANCES AND FUTURE OBLIGATIONS GOVERNED BY SECTION 443.055 RSMO THE TOTAL PRINCIPAL AMOUNT OF ALL OBLIGATIONS SECURED IS $6,100,000.00 MAXIMUM LIEN. The total principal amount of obligations at any one time which is secured by this Deed of Trust, in addition to any interest and any amounts advanced by Lender for the protection of the security interests grant

November 13, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 13, 2015 EX-99

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, November 13, 2015 ? Reliv International, Inc.

November 13, 2015 EX-10.1

Promissory Note (term loan) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.1 PROMISSORY NOTE Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,249,500.74 09-30-2015 09-30-2018 8197231 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV' INT

November 13, 2015 EX-10.2

Promissory Note (revolving credit facility) dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.2 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.2 PROMISSORY NOTE Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,500,000.00 09-30-2015 09-30-2016 8197223 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RELIV' INT

November 13, 2015 EX-10.3

Business Loan Agreement dated September 30, 2015 among Reliv International, Inc., Reliv, Inc., Reliv World Corporation, and SL Technology, Inc., as Borrowers and Enterprise Bank & Trust (incorporated by reference to Exhibit 10.3 to the Form 10-Q of the Registrant filed November 13, 2015).

Exhibit 10.3 BUSINESS LOAN AGREEMENT Principal Loan Date Maturity Loan No Call / Coll Account Officer Initials $3,249,500.74 09-30-2015 09-30-2018 8197231 1E / 59 *** References in the boxes above are for Lender's use only and do not limit the applicability of this document to any particular loan or item. Any item above containing "***" has been omitted due to text length limitations. Borrower: RE

November 13, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

November 5, 2015 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2015 RELIV? INTERNATIONAL, INC.

October 1, 2015 8-K

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

September 2, 2015 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2015 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer o

August 14, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 14, 2015 EX-99

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, August 14, 2015 ? Reliv International, Inc.

August 14, 2015 8-K

Reliv' International FORM 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commiss

June 17, 2015 11-K

Reliv' International FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION

May 26, 2015 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 15, 2015 EX-3.2

BY-LAWS OF RELIV’ INTERNATIONAL, INC. ARTICLE I — OFFICES

Exhibit 3.2 BY-LAWS OF RELIV? INTERNATIONAL, INC. ARTICLE I ? OFFICES SECTION 1. REGISTERED OFFICE. ?The registered office shall be established and maintained at CSC, 1013 Centre Road, City of Wilmington in the County of New Castle in the State of Delaware. SECTION 2. OTHER OFFICES. ?The corporation may have other offices, either within or without the State of Delaware, at such place or places as

May 15, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

April 30, 2015 EX-99

Reliv International Reports First-Quarter Financial Results for 2015

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2015 CHESTERFIELD, MO, April 30, 2015 ? Reliv International, Inc.

April 30, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2015 RELIV? INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

April 6, 2015 DEF 14A

Reliv' International FORM DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

April 1, 2015 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

April 1, 2015 EX-3.1

AMENDED AND RESTATED ARTICLE IX INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS

EXHIBIT 3.1 AMENDED AND RESTATED ARTICLE IX INDEMNIFICATION OF OFFICERS, DIRECTORS, EMPLOYEES AND AGENTS SECTION 1. The corporation shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporatio

March 24, 2015 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2014 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13

March 24, 2015 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 6, 2015 EX-10.1

SECOND AMENDMENT TO CREDIT AGREEMENT

Exhibit 10.1 SECOND AMENDMENT TO CREDIT AGREEMENT THIS SECOND AMENDMENT TO CREDIT AGREEMENT (this ?Amendment?) is made and entered into effective as of March 4, 2015, by and among Reliv? International, Inc., a Delaware corporation, Reliv?, Inc., an Illinois corporation, Reliv? World corporation, an Illinois corporation, and SL Technology, Inc., a Missouri corporation (each a ?Borrower? and collect

March 6, 2015 8-K

Current Report

8-K 1 v4039048k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 00

March 6, 2015 EX-10.2

February 27, 2015

Exhibit 10.2 February 27, 2015 Mr. Steven D. Albright Senior Vice President / Chief Financial Officer Reliv International, Inc. P.O. Box 405 Chesterfield, Mo 63005 Re: Loan Agreement dated February 28, 2014; (the ?Loan Agreement?), by and between Reliv International, Inc.; Reliv Inc.; Reliv World Corporation, and SL Technology, Inc.; (?Borrower?), and BMO Harris Bank N.A. (?Lender?). Capitalized t

March 4, 2015 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2014

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2014 CHESTERFIELD, MO, March 4, 2015 – Reliv International, Inc.

March 4, 2015 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2015 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

January 23, 2015 SC 13D

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

SC 13D 1 v399367sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63

November 19, 2014 S-8

RELV / Reliv' International, Inc. S-8 - - S-8

Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RELIV’ INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter) DELAWARE 37-1172197 (State of Incorporation) (I.R.S. Employer Identification Number) 136 Chesterfield Industrial Boulevard Chesterfield, Missouri 63005 (636) 5

November 19, 2014 EX-10.1

2014 Incentive Stock Plan (incorporated by reference to Exhibit 10.1 to the Form S-8 Registration Statement the Registrant filed November 19, 2014).

Exhibit 10.1 2014 INCENTIVE STOCK PLAN SECTION 1 General Purpose of the Plan; Definitions The name of the plan is the Reliv International, Inc. 2014 Incentive Stock Plan (the “Plan”). The purpose of the Plan is to encourage and enable officers and employees of, and other persons providing services to, Reliv International, Inc. (the “Company”) and its Affiliates to acquire a proprietary interest in

November 19, 2014 EX-24

POWER OF ATTORNEY REGISTRATION STATEMENT ON FORM S-8 RELIV’ INTERNATIONAL, INC.

Exhibit 24 POWER OF ATTORNEY REGISTRATION STATEMENT ON FORM S-8 RELIV’ INTERNATIONAL, INC.

November 19, 2014 EX-10.4

Form of RELIV’ INTERNATIONAL, INC. RESTRICTED STOCK AGREEMENT

Exhibit 10.4 Form of RELIV’ INTERNATIONAL, INC. RESTRICTED STOCK AGREEMENT THIS RESTRICTED STOCK AGREEMENT, made and entered into this day of , 20, between Reliv’ International, Inc. (hereinafter the “Company”), and (hereinafter “Employee”). WHEREAS, the Company has employed Employee and continues to employ Employee as of this date; and WHEREAS, the Company, as a further incentive to Employee to d

November 19, 2014 EX-10.2

Form of RELIV' INTERNATIONAL, INC. INCENTIVE STOCK OPTION AGREEMENT

Exhibit 10.2 Form of RELIV' INTERNATIONAL, INC. INCENTIVE STOCK OPTION AGREEMENT 1. Grant of Option This Incentive Stock Option Agreement constitutes and evidences the grant by Reliv International, Inc. (the “Company”) on (the “Grant Date”) to , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2014 Ince

November 19, 2014 EX-10.3

Form of RELIV’ INTERNATIONAL, INC. NON-STATUTORY STOCK OPTION AGREEMENT

Exhibit 10.3 Form of RELIV’ INTERNATIONAL, INC. NON-STATUTORY STOCK OPTION AGREEMENT 1. Grant of Option This Incentive Stock Option Agreement constitutes and evidences the grant by Reliv International, Inc. (the “Company”) on (the “Grant Date”) to , an employee of the Company (the “Participant”), of an option to purchase, in whole or in part, on the terms provided herein and in the Company’s 2014

November 14, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

October 30, 2014 EX-99

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, October 30, 2014 – Reliv International, Inc.

October 30, 2014 EX-10.1

FIRST AMENDMENT TO CREDIT AGREEMENT

Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this “Amendment”) is made and entered into effective as of October 29, 2014, by and among Reliv’ International, Inc., a Delaware corporation, Reliv’, Inc., an Illinois corporation, Reliv’ World corporation, an Illinois corporation, and SL Technology, Inc., a Missouri corporation (each a “Borrower” and collec

October 30, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

October 30, 2014 8-K

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2014 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

August 13, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

July 31, 2014 EX-99

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, July 31, 2014 – Reliv International, Inc.

July 31, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

June 19, 2014 11-K

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

May 14, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

April 30, 2014 EX-99

Reliv International Reports First-Quarter Financial Results for 2014

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2014 CHESTERFIELD, MO, April 30, 2014 – Reliv International, Inc.

April 30, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

April 11, 2014 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

April 3, 2014 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

April 3, 2014 EX-10.1

Carl W. Hastings Employment Agreement dated March 31, 2014 (incorporated by reference to Exhibit 10.1 to the Form 8-K of the Registrant filed April 3, 2014).

EXHIBIT 10.1 E M P L O Y M E N T A G R E E M E N T THIS AGREEMENT is made and entered into this 31st day of March, 2014, effective from January 1, 2013 and for the term provided herein, by and between Reliv' International, Inc., a Delaware corporation (the "Company") and Carl W. Hastings (hereinafter referred to as the "Executive"). WHEREAS, the Executive is presently, and for some time has been,

March 25, 2014 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

EX-21 2 v371506ex21.htm EXHIBIT 21 Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of N

March 25, 2014 10-K

ANNUAL REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2013 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13

March 6, 2014 EX-10.1

IMAGE OMITTED Credit Agreement dated as of February 28, 2014, Reliv’ International, Inc., Reliv’, Inc., Reliv’ World Corporation, and SL Technology, Inc., as Borrowers BMO Harris Bank N.A. SECTION 1. Table of Contents

Exhibit 10.1 IMAGE OMITTED Credit Agreement dated as of February 28, 2014, among Reliv’ International, Inc., Reliv’, Inc., Reliv’ World Corporation, and SL Technology, Inc., as Borrowers and BMO Harris Bank N.A. SECTION 1. Table of Contents SECTION 1. DEFINITIONS; INTERPRETATION. 1 Section 1.1 Definitions 1 Section 1.2 Interpretation 11 Section 1.3 Change in Accounting Principles.. 11 SECTION 2. T

March 6, 2014 8-K

- 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2014 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

March 5, 2014 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2014 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

March 5, 2014 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2013 CHESTERFIELD, MO, March 5, 2014 – Reliv International, Inc.

February 18, 2014 SC 13D

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 RELIV INTERNATIONAL INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 75952 R 100 (CUSIP Number) Robert L. Montgomery, Chief Executive Officer 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (636)537-9715 (Name, Address

November 18, 2013 8-K

- 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2013 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 1-11768 37-1172197 (State or other jurisdiction (Commission (IRS Employer o

November 14, 2013 10-Q

Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

October 31, 2013 EX-99

Reliv International Reports Third-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, MO, October 31, 2013 – Reliv International, Inc.

October 31, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

August 14, 2013 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 1, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

August 1, 2013 EX-99

Reliv International Reports Second-Quarter Financial Results

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, MO, August 1, 2013 – Reliv International, Inc.

July 25, 2013 EX-10.2

Agreement by and among Reliv International, Inc., SL Technology, Inc., Soy Labs, LLC and 1Soy, Inc. dated July 23, 2013 (incorporated by reference to Exhibit 10.2 to the Form 8-K of the Registrant filed July 25, 2013).

Exhibit 10.2 AGREEMENT THIS AGREEMENT is made and entered into this 23rd day of July, 2013, by and among Reliv International, Inc., a Delaware corporation (“Reliv”), Soy Labs, LLC, a Missouri limited liability company (“Soy Labs”), SL Technology, Inc., a Missouri corporation (“SL”) and 1Soy, Inc., a Missouri non-stock cooperative marketing association (“1Soy”). WHEREAS, concurrently with this Agre

July 25, 2013 EX-10.1

Technology License Agreement by and between SL Technology, Inc. and Soy Labs, LLC dated July 23, 2013 (incorporated by reference to Exhibit 10.1 to the Form 8-K of the Registrant filed July 25, 2013).

Exhibit 10.1 TECHNOLOGY LICENSE AGREEMENT This Technology License Agreement (“Agreement”) is made as of the 23rd day of July 2013 (“the Effective Date”) by and between SL Technology, Inc., a corporation duly organized and existing under the laws of the State of Missouri, having a principal place of business at 136 Chesterfield Industrial Boulevard, Chesterfield, Missouri 63005 (hereinafter referre

July 25, 2013 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

July 25, 2013 EX-99

Reliv Acquires Exclusive Rights to ‘Superfood’ Lunasin Deal positions Reliv as industry leader in emerging field of nutritional epigenetics

Exhibit 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv Acquires Exclusive Rights to ‘Superfood’ Lunasin Deal positions Reliv as industry leader in emerging field of nutritional epigenetics CHESTERFIELD, MO, July 24, 2013 – Reliv International, Inc.

June 14, 2013 11-K

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

June 6, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 29, 2013 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 15, 2013 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

May 1, 2013 EX-99

Reliv International Reports First-Quarter Financial Results for 2013

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Mark Murphy Chief Financial Officer Investor Relations Media Relations (636) 733-1305 (636) 733-1314 (636) 733-1391 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2013 CHESTERFIELD, Mo.

May 1, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

April 8, 2013 DEF 14A

- DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

March 26, 2013 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 OR ? TRANSITION REPORT PURSUANT TO SECTION 13

March 26, 2013 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

March 6, 2013 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2012

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2012 CHESTERFIELD, Missouri, March 6, 2013 – Reliv International, Inc.

March 6, 2013 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

February 27, 2013 SC 13G/A

RELV / Reliv' International, Inc. / Montgomery Robert L - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 18)* Reliv International, Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 75952 R 100 (CUSIP Number) February 27, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule

February 12, 2013 8-K

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2013 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

January 22, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 17, 2013 RELIV INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 000-19932 37-1172197 (State or other jurisdiction (Commission (IRS Employer

November 14, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 1, 2012 EX-99

Reliv International Reports Third-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, Missouri, October 31, 2012 – Reliv International, Inc.

November 1, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

October 4, 2012 EX-10.1

EX-10.1

Exhibit 10.1

October 4, 2012 EX-10.2

EX-10.2

v325022ex10-2 - Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing Exhibit 10.2

October 4, 2012 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Comm

August 14, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

August 1, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissi

August 1, 2012 EX-99

Reliv International Reports Second-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Second-Quarter Financial Results CHESTERFIELD, Missouri, August 1, 2012 – Reliv International, Inc.

July 25, 2012 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commissio

June 21, 2012 11-K

- FORM 11-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 11-K FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILARY PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR ¨ TRANSITION REPORT PURSUANT TO SECTION

May 22, 2012 8-K

Submission of Matters to a Vote of Security Holders - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 17, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commission

May 14, 2012 EX-10.1

Loan Sale Agreement between 2010-1 RADC/CADC Venture, LLC and Reliv International, Inc. dated March 16, 2012 (incorporated by reference to Exhibit 10.1 to the Form 10-Q of the Registrant for the quarter ended March 31, 2012).

Exhibit 10.1 LOAN SALE AGREEMENT This Loan Sale Agreement (this “Agreement”) is made effective as of March 16, 2012 (the “Effective Date”), between 2010-1 RADC/CADC Venture, LLC (“Seller”), and Reliv’ International, Inc. (“Buyer”). Recitals A. Seller is the current owner and holder of a loan (the “Loan”) evidenced by (among other things) the following documents (collectively, the “Loan Documents”)

May 14, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ I

May 2, 2012 EX-99

Reliv International Reports First-Quarter Financial Results for 2012

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports First-Quarter Financial Results for 2012 CHESTERFIELD, Missouri, May 2, 2012 – Reliv International, Inc.

May 2, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 v3115578k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-

April 6, 2012 DEF 14A

-

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin

March 23, 2012 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 (Mark One) S ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 OR £ TRANSITION REPORT PURSUANT TO SECTION 13

March 23, 2012 EX-21

Reliv International, Inc. Subsidiaries of Registrant1

Exhibit 21 Reliv International, Inc. Subsidiaries of Registrant1 Nutrition 2000, Inc., a Delaware corporation Reliv, Inc., an Illinois corporation Reliv World Corporation, an Illinois corporation Reliv Europe, Inc., an Illinois corporation Reliv Australia Pty, Limited, organized under the laws of Australia Reliv New Zealand, Limited, organized under the laws of New Zealand Reliv Now de Mexico, S.

February 29, 2012 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 29, 2012 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commi

February 29, 2012 EX-99

Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2011

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright or: Fred Nielson Chief Financial Officer Investor Relations (636) 733-1305 (636) 733-1314 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Fourth-Quarter and Full-Year Financial Results for 2011 CHESTERFIELD, Missouri, February 29, 2012 – Reliv International, Inc.

February 10, 2012 SC 13G/A

RELV / Reliv' International, Inc. / Montgomery Robert L Passive Investment

SC 13G/A 1 v302067sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 17)* Reliv International, Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 75952 R 100 (CUSIP Number) February 10, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropria

November 14, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELI

November 2, 2011 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 RELIV’ INTERNATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2011 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

November 2, 2011 EX-99

Reliv International Reports Third-Quarter Financial Results

EXHIBIT 99 NEWS RELEASE For more information, contact: Steve Albright Chief Financial Officer (636) 733-1305 FOR IMMEDIATE DISTRIBUTION Reliv International Reports Third-Quarter Financial Results CHESTERFIELD, Missouri, November 2, 2011 ? Reliv International, Inc.

November 1, 2011 8-K

Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2011 RELIV’ INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 000-19932 37-1172197 (Commis

November 1, 2011 EX-10.1

EX-10.1

Exhibit 10.1

August 15, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-19932 RELIV’ IN

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista